George Sellers
Stock Analyst at Stephens & Co.
(1.33)
# 3,488
Out of 4,944 analysts
43
Total ratings
27.27%
Success rate
-7.09%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $38.34 | +77.36% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $122.92 | +135.93% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $37.93 | +52.91% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $132.04 | +34.81% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $9.10 | +163.74% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $29.59 | +143.33% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $2.36 | +111.86% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $6.90 | +262.32% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $28.21 | +102.06% | 6 | Aug 14, 2023 | |
| GKOS Glaukos | Reiterates: Overweight | $71 | $91.79 | -22.65% | 4 | May 8, 2023 |
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $38.34
Upside: +77.36%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $122.92
Upside: +135.93%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $37.93
Upside: +52.91%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $132.04
Upside: +34.81%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $9.10
Upside: +163.74%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $29.59
Upside: +143.33%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $2.36
Upside: +111.86%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $6.90
Upside: +262.32%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $28.21
Upside: +102.06%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $91.79
Upside: -22.65%